Disulfiram Overcomes Cisplatin Resistance in Human Embryonal Carcinoma Cells

Silvia Schmidtova1, Katarina Kalavska2,3,4, Katarina Gercakova2

  • 1Cancer Research Institute, Biomedical Research Center, University Science Park for Biomedicine, Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovakia. silvia.schmidtova@savba.sk.

Cancers
|August 25, 2019
PubMed

Insights

Cisplatin resistance in testicular germ cell tumors is a challenge. Researchers identified ALDH1A3 as a therapeutic target and found disulfiram effective in overcoming chemoresistance in these cancers.

Area of Science:

  • Oncology
  • Cancer Research
  • Pharmacology

Background:

  • Cisplatin resistance presents a significant clinical challenge in treating testicular germ cell tumors (TGCTs).
  • Cancer stem cell (CSC) markers are implicated in chemoresistance, necessitating investigation into novel therapeutic strategies.
  • Understanding the mechanisms of chemoresistance is crucial for developing effective treatments for refractory TGCTs.

Purpose of the Study:

  • To investigate mechanisms of cisplatin resistance in TGCTs, focusing on cancer stem cell markers.
  • To identify potential therapeutic targets and modalities to overcome chemoresistance in TGCTs.
  • To evaluate disulfiram as a chemosensitizing agent in cisplatin-resistant TGCT models.

Main Methods:

  • Development and characterization of cisplatin-resistant (CisR) TGCT cell lines (NTERA-2, NCCIT) using flow cytometry, gene expression, and protein arrays.
  • Assessment of tumorigenicity in immunodeficient mouse models.
  • Evaluation of ALDH1A3 expression via immunohistochemistry in 216 patient samples and in vitro assays.
  • Testing the synergistic effect of disulfiram and cisplatin on resistant cells and xenografts.

Main Results:

  • CisR cells exhibited significantly increased resistance to platinum-based chemotherapeutics (cisplatin, carboplatin, oxaliplatin).
  • NTERA-2 CisR cells showed altered morphology, increased tumorigenicity, high ALDH1A3 expression, and elevated ALDH activity.
  • Disulfiram combined with cisplatin demonstrated synergistic effects in resistant cell lines and inhibited xenograft growth.
  • Elevated ALDH1A3 expression was observed in TGCT patient tissues compared to normal testicular tissue.

Conclusions:

  • A novel, clinically relevant model of chemoresistant TGCTs was characterized.
  • ALDH1A3 was identified as a potential therapeutic target for overcoming cisplatin resistance in TGCTs.
  • Disulfiram represents a promising treatment option for patients with refractory TGCTs, particularly in combination with cisplatin.

Related Concept Videos

Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.1K
Embryonic Stem Cells00:57

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
4.7K
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems01:22

Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems

Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
194
Resistivity01:22

Resistivity

When a voltage is applied to a conductor, an electrical field is generated, and charges in the conductor feel the force due to the electrical field. The current density that results depends on the electrical field and the properties of the material. In some materials, including metals at a given temperature, the current density is approximately proportional to the electrical field. In these cases, the current density can be modeled as:
4.4K
Resistance01:19

Resistance

When a current moves through any conductor, the conductor causes some level of difficulty for the current to flow. The measure of that difficulty is known as the resistance of the material and is represented by R. Every material has its own resistance. In the case of conductors, heat is emitted whenever a current passes through them. Resistance depends on the resistivity of the material. Resistivity is a characteristic of the material used to fabricate electrical components, whereas the...
5.7K
Resistance and Conductance01:25

Resistance and Conductance

A conductor's DC resistance at a given temperature is influenced by its resistivity, length, and cross-sectional area. Resistivity is an inherent property of the conductor material, with annealed copper serving as the international standard for measurement. For instance, the resistivity of hard-drawn aluminum at 20 degrees Celsius is 61% of the standard conductivity of annealed copper.
Various factors impact the resistance of a conductor. Spiraling in stranded conductors increases their...
492